ESSA Pharma Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ESSA Pharma Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2024.
  • ESSA Pharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $295K, a 334% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $295K +$227K +334% Sep 30, 2024 10-K 2024-12-17
Q2 2024 $318K +$223K +234% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $341K +$215K +171% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $363K +$207K +133% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $68K -$118K -63.5% Sep 30, 2023 10-K 2024-12-17
Q2 2023 $95.2K -$122K -56.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $126K -$122K -49.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $156K -$122K -43.8% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $186K -$122K -39.5% Sep 30, 2022 10-K 2024-12-17
Q2 2022 $217K -$80.6K -27.1% Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $247K -$93.7K -27.5% Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $278K +$250K +907% Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $308K +$253K +459% Sep 30, 2021 10-K 2023-12-12
Q2 2021 $298K +$215K +260% Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $341K +$231K +209% Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $27.6K -$110K -80% Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $55.2K +$55.2K Sep 30, 2020 10-K 2022-12-13
Q2 2020 $82.7K Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $110K Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $138K Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $0 Sep 30, 2019 10-K 2021-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.